Evaluating the impact of biannual school-based and community-wide treatment on urogenital schistosomiasis in Niger

Table 1 Treatment coverage by Group over time

Year (Y)	Study group	SAC treated	SAC total	Mean % SAC treated^a	Total population treated	Total population eligible for treatment	% total population treated
Y1	A1	16,563	20,267	82
	A2	18,986	18,809	101
	B1	20,382	24,670	83
	B2	25,281	30,373	83
	C1	22,479	17,598	128	43,600	58,648	74
	C2	26,373	25,133	105	57,058	83,772	68
Y2	A1	15,053	13,425	112
	A2	13,553	14,309	95
	B1	19,322	17,378	111
	B2	16,345	17,227	95
	C1	23,512	18,123	130	47,031	60,410	78
	C2	33,735	25,883	130	66,671	86,287	77
Y3 Treatment 1	A1	23,281	23,021	101
	A2	25,174	23,586	107
	B1	28,406	22,999	124
	B2	33,231	27,781	120
	C1	26,306	19,663	134	51,598	52,434	98
	C2	39,311	24,415	161	74,558	65,106	115
Y3 Treatment 2	A1	0	23,021
	A2	28,203	23,586	120
	B1	0	22,999
	B2	25,274	27,781	91
	C1	0	19,663			52,434
	C2	33,003	24,415	135	61,182	65,106	94
Y4 Treatment 1	A1	20,708	25,368	82
	A2	18,178	21,528	85
	B1	27,316	29,813	92
	B2	29,202	33,822	86
	C1	22,664	19,042	120	42,464	50,761	84
	C2	33,861	25,866	131	55,831	68,967	81
Y4 Treatment 2	A1	0	25,368
	A2	16,309	21,528	76
	B1	0	29,813
	B2	26,247	33,822	78
	C1	0	19,042			50,761
	C2	29,290	25,866	113	54,539	68,967	79

ISSN: 1756-3305